Reckitt Benckiser (OTCMKTS:RBGLY) – Stock analysts at Jefferies Group decreased their FY2018 earnings per share (EPS) estimates for shares of Reckitt Benckiser in a note issued to investors on Monday, April 9th. Jefferies Group analyst M. Deboo now forecasts that the company will earn $0.89 per share for the year, down from their previous forecast of $0.91. Jefferies Group also issued estimates for Reckitt Benckiser’s FY2019 earnings at $0.94 EPS and FY2020 earnings at $0.99 EPS.
A number of other research analysts have also recently commented on RBGLY. Credit Suisse Group restated a “neutral” rating on shares of Reckitt Benckiser in a research note on Tuesday, February 20th. Zacks Investment Research upgraded Reckitt Benckiser from a “strong sell” rating to a “hold” rating in a research note on Wednesday, December 20th. Societe Generale upgraded Reckitt Benckiser from a “hold” rating to a “buy” rating in a research note on Thursday, March 22nd. JPMorgan Chase restated a “buy” rating on shares of Reckitt Benckiser in a research note on Monday, December 18th. Finally, Deutsche Bank restated a “buy” rating on shares of Reckitt Benckiser in a research note on Friday, March 23rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Reckitt Benckiser currently has an average rating of “Hold” and a consensus price target of $21.00.
Shares of Reckitt Benckiser stock opened at $17.38 on Tuesday. Reckitt Benckiser has a twelve month low of $15.80 and a twelve month high of $21.79.
ILLEGAL ACTIVITY WARNING: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/10/reckitt-benckiser-expected-to-earn-fy2018-earnings-of-0-89-per-share-rbgly.html.
About Reckitt Benckiser
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl, and Strepsils brand names.
Receive News & Ratings for Reckitt Benckiser Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser and related companies with MarketBeat.com's FREE daily email newsletter.